EPGNF:OTCPK (Germany) Also trade in: Germany UK

Epigenomics AG

$ 2.13 0 (0%)
Volume: 0 Avg Vol (1m): 3,318
Market Cap $: 79.65 Mil Enterprise Value $: 60.30 Mil
P/E (TTM): 0.00 P/B: 3.08
Earnings Power Value -5.01
Net Current Asset Value 0.56
Tangible Book 0.68
Projected FCF -2.02
Median P/S Value 1.76
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
YTD (-%)

Financial Strength : 7/10

Current vs industry vs history
Cash-to-Debt No Debt
Equity-to-Asset 0.85
Debt-to-EBITDA -0.55
Piotroski F-Score 3
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.33
DISTRESS
GREY
SAFE
Beneish M-Score -3.47
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC -445.64%
WACC 6.36%

Profitability & Growth : 2/10

Current vs industry vs history
Operating Margin % -813.37
Net Margin % -827.98
ROE % -143.29
ROA % -74.71
ROC (Joel Greenblatt) % -1500.35
3-Year Total Revenue Growth Rate -9.70
N/A
3-Year Total EBITDA Growth Rate -13.60
3-Year EPS w/o NRI Growth Rate 1.00

» EPGNF's 30-Y Financials

Financials (Next Earnings Date: )

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with OTCPK:EPGNF

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Diagnostics & Research » Diagnostics & Research    NAICS : 0    SIC : 0
Compare NAS:HTGM WAR:BKM LSE:ONC OSTO:CRAD B NZSE:PEB XAMS:CURE NAS:CEMI XKRX:084650 XKRX:950140 NAS:VRML NAS:TRIB NAS:PMD XTER:LIO1 PHS:DNA TSE:7707 ROCO:6615 OCSE:BIOPOR TSE:9707 XKRX:217600 LSE:AGL
Traded in other countries ECXV.Germany 0QXH.UK
Address Geneststrasse 5, Berlin, DEU, 10829
Epigenomics AG was founded as a limited liability company (GmbH) in 1998. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer.

Ratios

Current vs industry vs history
PB Ratio 3.08
PS Ratio 32.05
EV-to-EBIT -3.86
EV-to-EBITDA -3.96
EV-to-Revenue 32.40
Current Ratio 5.77
Quick Ratio 5.66
Days Inventory 274.58
Days Sales Outstanding 39.05
Days Payable 1.00

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -14.30

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 3.13
Price-to-Median-PS-Value 1.21
Earnings Yield (Joel Greenblatt) % -25.90

More Statistics

Revenue (TTM) (Mil) $ 1.8
EPS (TTM) $ -0.55
Beta 0.69
Volatility % 36.35
52-Week Range $ 1.8 - 4.55
Shares Outstanding (Mil) 36.02

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 3
Positive ROA N
Positive CFROA N
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N